Tsujimoto N - Search Results

1

Safety of baricitinib in Japanese patients with rheumatoid arthritis in clinical use: 3-year data of all-case post-marketing surveillance study.

Okamoto N, Atsumi T, Takagi M, Takahashi N, Takeuchi T, Tamura N, Nakajima A, Nakajima A, Fujii T, Matsuno H, Ishii T, Tsujimoto N, Nishikawa A, Minatoya M, Tanaka Y, Kuwana M. Okamoto N, et al. Among authors: tsujimoto n. Mod Rheumatol. 2024 Aug 9:roae064. doi: 10.1093/mr/roae064. Online ahead of print. Mod Rheumatol. 2024. PMID: 39119689

2

Real-World Safety and Effectiveness of Tadalafil in Patients with Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Japanese Post-Marketing Surveillance Study.

Yamazaki H, Tsujimoto N, Koyanagi M, Katoh MC, Tajima K, Komori M. Yamazaki H, et al. Among authors: tsujimoto n. Pragmat Obs Res. 2020 May 4;11:45-54. doi: 10.2147/POR.S237821. eCollection 2020. Pragmat Obs Res. 2020. PMID: 32440247 Free PMC article.

3

Safety and effectiveness of baricitinib for rheumatoid arthritis in Japanese clinical practice: 24-week results of all-case post-marketing surveillance.

Takagi M, Atsumi T, Matsuno H, Tamura N, Fujii T, Okamoto N, Takahashi N, Nakajima A, Nakajima A, Tsujimoto N, Nishikawa A, Ishii T, Takeuchi T, Kuwana M. Takagi M, et al. Among authors: tsujimoto n. Mod Rheumatol. 2023 Jul 4;33(4):647-656. doi: 10.1093/mr/roac089. Mod Rheumatol. 2023. PMID: 35932218

4

Validation Study of Algorithms to Identify Malignant Tumors and Serious Infections in a Japanese Administrative Healthcare Database.

Nishikawa A, Yoshinaga E, Nakamura M, Suzuki M, Kido K, Tsujimoto N, Ishii T, Koide D. Nishikawa A, et al. Among authors: tsujimoto n. Ann Clin Epidemiol. 2022 Jan 7;4(1):20-31. doi: 10.37737/ace.22004. eCollection 2022. Ann Clin Epidemiol. 2022. PMID: 38505283 Free PMC article.

5

Utilization of glucagon-like peptide-1 receptor agonists and changes in clinical characteristics in patients with type 2 diabetes by chronic kidney disease stage in Japan: A descriptive observational study using a nationwide electronic medical records database.

Hirose N, Tsujimoto N, Katayose T, Chin R. Hirose N, et al. Among authors: tsujimoto n. Diabetes Obes Metab. 2022 Mar;24(3):486-498. doi: 10.1111/dom.14600. Epub 2021 Dec 5. Diabetes Obes Metab. 2022. PMID: 34779098 Free PMC article.

6

Merestinib monotherapy or in combination for japanese patients with advanced and/or metastatic cancer: A phase 1 study.

Doi T, Yamamoto N, Naito Y, Kuboki Y, Koyama T, Piao Y, Tsujimoto N, Asou H, Inoue K, Kondo S. Doi T, et al. Among authors: tsujimoto n. Cancer Med. 2021 Oct;10(19):6579-6589. doi: 10.1002/cam4.4110. Epub 2021 Sep 9. Cancer Med. 2021. PMID: 34499416 Free PMC article. Clinical Trial.

7

Comparative Effectiveness of Biologic Classes in Clinical Practice: Month 12 Outcomes from the International Observational Psoriasis Study of Health Outcomes (PSoHO).

Khattri S, González-Cantero Á, Engin B, Dogra S, Murphy CA, Schuster C, Tsujimoto N, Martimianaki G, Lampropoulou A, Alsharafi A, Konicek B, Lauffer F. Khattri S, et al. Among authors: tsujimoto n. Adv Ther. 2024 Nov 9. doi: 10.1007/s12325-024-03034-1. Online ahead of print. Adv Ther. 2024. PMID: 39520657

8

Concomitant sarcopenia and undernutrition: Impact on clinical outcomes in patients undergoing hemodialysis.

Tsujimoto N, Matsuzawa R, Kakita D, Imai H, Harada M, Yoshikoshi S, Yamabe S, Osada S, Shimokado K, Matsunaga A, Tamaki A. Tsujimoto N, et al. Clin Nutr ESPEN. 2024 Oct;63:651-658. doi: 10.1016/j.clnesp.2024.07.1059. Epub 2024 Aug 2. Clin Nutr ESPEN. 2024. PMID: 39098604

9

Predictors indicating the continuous need for a knee-ankle-foot orthosis in stroke patients at 1 month after onset.

Tsujimoto N, Abe H, Okanuka T, Seki T, Fujimura M. Tsujimoto N, et al. J Stroke Cerebrovasc Dis. 2023 Dec;32(12):107425. doi: 10.1016/j.jstrokecerebrovasdis.2023.107425. Epub 2023 Nov 10. J Stroke Cerebrovasc Dis. 2023. PMID: 37952269

10

Evaluation of a Method to Estimate Foot Eversion Moments During the Support Phase of Running.

Tsujimoto N. Tsujimoto N. J Am Podiatr Med Assoc. 2023 Sep-Oct;113(5):21-068. doi: 10.7547/21-068. J Am Podiatr Med Assoc. 2023. PMID: 37934600

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters